newsfilter
← Latest News
GlobeNewswire·

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results

Continued Progress in Ongoing Late-Stage Netherton Syndrome Studies Announced Positive Clinical Data for Adult and Pediatric Netherton Patients Provided Clear Visual Evidence of QRX003 Mechanism of Action Patent